Concourse Financial Group Securities, Inc. Lexaria Bioscience Corp. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

19 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$0.85 - $1.69 $0 - $0
Q1 2025 May 14, 2025	BUY	$1.22 - $2.29 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$2.01 - $3.3 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$2.58 - $4.09 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.99 - $4.0 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.29 - $6.25 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.92 - $1.69 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.72 - $1.11 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.72 - $1.11 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.69 - $2.69 $0 - $0
Q1 2023 May 15, 2023	BUY	$2.47 - $3.47 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.95 - $2.98 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.74 - $3.28 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.88 - $4.06 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.78 - $4.7 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.87 - $6.9 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$5.39 - $8.44 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$4.61 - $7.02 $0 - $0
Q1 2021 May 13, 2021	BUY	$4.26 - $8.38 $0 - $0

Others Institutions Holding LEXX

# of Institutions

Shares Held

2.48M

Call Options Held

Put Options Held

Sabby Management, LLC Upper Saddle River, NJ

1.17M
Shares

$1.21 Million
25.66% of portfolio
Invenomic Capital Management LP Boston, MA

501K
Shares

$521,526
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

259K
Shares

$269,168
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

175K
Shares

$181,770
0.0% of portfolio
Toronto Dominion Bank Toronto, Ontario, A6

133K
Shares

$138,450
0.0% of portfolio

View Full List

About Lexaria Bioscience Corp.

Ticker LEXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,951,000
Market Cap $6.19M
Description
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...

More about LEXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account